Market Tracker

06/22 5:15pm ET

ChemoCentryx Inc (NASDAQ:CCXI)

12.03
Delayed Data
As of Jun 22
 +0.53 / +4.61%
Today’s Change
5.42
Today|||52-Week Range
15.08
+102.18%
Year-to-Date
ChemoCentryx, 58.com, Seagate, Garmin and Texas Instruments as Zacks Bull and Bear of...
Jun 22 / Zacks.com - Paid Partner Content
Bear of the Day: 58.com (WUBA)
Jun 22 / Zacks.com - Paid Partner Content
Bull of the Day: ChemoCentryx (CCXI)
Jun 22 / Zacks.com - Paid Partner Content
PTC Therapeutics (PTCT) Jumps: Stock Rises 7.2%
Jun 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close11.50
Today’s open11.60
Day’s range11.48 - 12.05
Volume596,489
Average volume (3 months)309,277
Market cap$546.1M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-363.69%
Earnings growth (next 5 years)--
Revenue growth (last year)+591.22%
P/E ratio41.5
Price/Sales3.58
Price/Book6.84

Competitors

 Today’s
change
Today’s
% change
RARXRa Pharmaceuticals I...+0.26+2.84%
TTPHTetraphase Pharmaceu...+0.02+0.50%
CNCEConcert Pharmaceutic...-0.27-1.37%
AQXPAquinox Pharmaceutic...+0.79+5.37%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$82.5M
Annual profit (last year)$17.9M
Net profit margin21.65%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Thomas J. Schall
Chief Operating Officer &
Executive Vice President
William Fairey
Corporate headquarters
Mountain View, California

Forecasts